Lantheus Alpha Therapy, LLC
10% owner
- Shares
- 167,149
- Price
- $3.15
- Value
- $526,051
CATX
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$1,622,534
0 buyers · 2 sellers
12-month purchases
$42,241
2 distinct insiders
12-month sales
$1,622,534
2 distinct insiders
Highlighted alerts
9
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CATX overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 4, 2026, with a grant date of March 2, 2026 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2026. Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.
Voluntary purchases and sales; administrative noise stays hidden.
Lantheus Alpha Therapy, LLC
10% owner
Lantheus Alpha Therapy, LLC
10% owner
Lantheus Alpha Therapy, LLC
10% owner
Lantheus Alpha Therapy, LLC
10% owner
Lantheus Holdings, Inc.
10% owner
Lantheus Alpha Therapy, LLC
10% owner
Lantheus Holdings, Inc.
10% owner
Hunt Jonathan Robert
Chief Accounting Officer
Williamson Robert F III
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 04, 2026 | Lantheus Alpha Therapy, LLC 10% owner | Sale | 167,149 | $3.15 | $526,051 | |
| Sep 03, 2026 | Lantheus Alpha Therapy, LLC 10% owner | Sale | 80,783 | $3.11 | $250,896 | |
| Sep 02, 2026 | Lantheus Alpha Therapy, LLC 10% owner | Sale | 42,129 | $3.11 | $131,219 | |
| Sep 01, 2026 | Lantheus Alpha Therapy, LLC 10% owner | Sale | 35,769 | $3.12 | $111,574 | |
| Sep 01, 2026 | Lantheus Holdings, Inc. 10% owner | Sale | 35,769 | $3.12 | $111,574 | |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC 10% owner | Sale | 78,145 | $3.14 | $245,610 | |
| Aug 31, 2026 | Lantheus Holdings, Inc. 10% owner | Sale | 78,145 | $3.14 | $245,610 | |
| Nov 13, 2025 | Hunt Jonathan Robert Chief Accounting Officer | Purchase | 11,000 | $2.03 | $22,295 | |
| Nov 12, 2025 | Williamson Robert F III Director | Purchase | 9,498 | $2.10 | $19,946 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.